Not applicableUnknownNCT04122586
What this trial is testing
Mechanism of PERK - eIF2a Pathways in Intestinal Mucosal Barrier of IBS-D and the Role "Metabolism Ingredients" of Tongxieyaofang
Who this might be right for
IBS (Irritable Bowel Syndrome)
Xiyuan Hospital of China Academy of Chinese Medical Sciences 60